Agilent’s Electronic Measurement Business to be Distributed to Shareholders Through a Tax-Free Spinoff. From a strategic perspective, the division aims to increases the strategic flexibility of both standalone businesses. Highlights from Agilent’s press release include:
- Two publicly traded companies will offer shareholders distinct opportunities with unique investment identities
- $3.9 billion Agilent life sciences, diagnostics, applied markets company
- $2.9 billion electronic measurement company, to be named later
- Transaction leverages strategic and operational advancements and improvements of both businesses
- Allows management to focus exclusively on the customers of their respective companies
Follow Evolution Global Talent Attraction on Twitter, Facebook and LinkedIN to keep up-to-date with news and trends from the biotechnology, biosciences, medical device, IT and Intellectual Property industries.
